PRESS RELEASE Casey-Drew Williams 2/8/23 PRESS RELEASE Casey-Drew Williams 2/8/23 NGD CEO Paul Rhodes Announces Publication in the Journal of Clinical Microbiology Validating Machine Learning-Based Resistance Prediction Read More PRESS RELEASE Casey-Drew Williams 2/7/23 PRESS RELEASE Casey-Drew Williams 2/7/23 NGD CEO Paul Rhodes Announces Appointment of Brigitte Frankel to its Advisory Board Read More PRESS RELEASE Casey-Drew Williams 1/9/23 PRESS RELEASE Casey-Drew Williams 1/9/23 Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd. Read More PRESS RELEASE Casey-Drew Williams 9/22/22 PRESS RELEASE Casey-Drew Williams 9/22/22 Next Gen Diagnostics Announces Vanderbilt Professor and Leader in Antibiotic Susceptibility Testing Dr. Romney Humphries Has Joined Next Gen Diagnostics Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 9/19/22 PRESS RELEASE Casey-Drew Williams 9/19/22 Next Gen Diagnostics announces Cleveland Clinic Microbiology Laboratory Medical Director Dr. Daniel Rhoads has joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 3/26/20 PRESS RELEASE Casey-Drew Williams 3/26/20 Next Gen Diagnostics Announces that MIT Associate Professor and Broad Institute Core Faculty member Paul Blainey has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 3/3/20 PRESS RELEASE Casey-Drew Williams 3/3/20 Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing Read More PRESS RELEASE Casey-Drew Williams 7/11/18 PRESS RELEASE Casey-Drew Williams 7/11/18 Next Gen Diagnostics Announces that Dr. Tony Cox, Director of Advanced Sequencing Pipeline Research at the Wellcome Sanger Institute, Has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 1/10/18 PRESS RELEASE Casey-Drew Williams 1/10/18 Next Gen Diagnostics Selected to Partner with a UK Consortium To Conduct The First Trial Of Prospective Sequencing-Enabled Transmission Detection, At Addenbrooke’s Hospital, In Cambridge, UK. Read More PRESS RELEASE Casey-Drew Williams 11/1/17 PRESS RELEASE Casey-Drew Williams 11/1/17 Next Gen Diagnostics Announces that Professor Sharon Peacock, of the London School of Hygiene and Tropical Medicine, Has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 8/19/17 PRESS RELEASE Casey-Drew Williams 8/19/17 Next Gen Diagnostics Announces that Professor Julian Parkhill, Pathogen Genomics Group Leader at the Sanger Institute, Has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 6/30/17 PRESS RELEASE Casey-Drew Williams 6/30/17 Next Gen Diagnostics Announces the Opening of its Office at the Wellcome Trust Genome Campus Outside of Cambridge, UK Read More Newer Posts
PRESS RELEASE Casey-Drew Williams 2/8/23 PRESS RELEASE Casey-Drew Williams 2/8/23 NGD CEO Paul Rhodes Announces Publication in the Journal of Clinical Microbiology Validating Machine Learning-Based Resistance Prediction Read More
PRESS RELEASE Casey-Drew Williams 2/7/23 PRESS RELEASE Casey-Drew Williams 2/7/23 NGD CEO Paul Rhodes Announces Appointment of Brigitte Frankel to its Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 1/9/23 PRESS RELEASE Casey-Drew Williams 1/9/23 Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd. Read More
PRESS RELEASE Casey-Drew Williams 9/22/22 PRESS RELEASE Casey-Drew Williams 9/22/22 Next Gen Diagnostics Announces Vanderbilt Professor and Leader in Antibiotic Susceptibility Testing Dr. Romney Humphries Has Joined Next Gen Diagnostics Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 9/19/22 PRESS RELEASE Casey-Drew Williams 9/19/22 Next Gen Diagnostics announces Cleveland Clinic Microbiology Laboratory Medical Director Dr. Daniel Rhoads has joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 3/26/20 PRESS RELEASE Casey-Drew Williams 3/26/20 Next Gen Diagnostics Announces that MIT Associate Professor and Broad Institute Core Faculty member Paul Blainey has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 3/3/20 PRESS RELEASE Casey-Drew Williams 3/3/20 Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing Read More
PRESS RELEASE Casey-Drew Williams 7/11/18 PRESS RELEASE Casey-Drew Williams 7/11/18 Next Gen Diagnostics Announces that Dr. Tony Cox, Director of Advanced Sequencing Pipeline Research at the Wellcome Sanger Institute, Has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 1/10/18 PRESS RELEASE Casey-Drew Williams 1/10/18 Next Gen Diagnostics Selected to Partner with a UK Consortium To Conduct The First Trial Of Prospective Sequencing-Enabled Transmission Detection, At Addenbrooke’s Hospital, In Cambridge, UK. Read More
PRESS RELEASE Casey-Drew Williams 11/1/17 PRESS RELEASE Casey-Drew Williams 11/1/17 Next Gen Diagnostics Announces that Professor Sharon Peacock, of the London School of Hygiene and Tropical Medicine, Has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 8/19/17 PRESS RELEASE Casey-Drew Williams 8/19/17 Next Gen Diagnostics Announces that Professor Julian Parkhill, Pathogen Genomics Group Leader at the Sanger Institute, Has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 6/30/17 PRESS RELEASE Casey-Drew Williams 6/30/17 Next Gen Diagnostics Announces the Opening of its Office at the Wellcome Trust Genome Campus Outside of Cambridge, UK Read More
